Research Unit

Bioethics Institute Ghent

Acronym
BIG
Duration
19 April 2019 → Ongoing
Group leader
Other information
Research disciplines
  • Humanities and the arts
    • Bioethics
Keywords
Ethics and morality Philosophy
Description
The Bioethics Institute Ghent (BIG) at Ghent University is based at the Faculty of Arts and Philosophy and is a subdivision of the Department of Philosophy and Moral Sciences. It serves as a meeting point for academics teaching and conducting research on bioethical issues at any Ghent University department. Bioethics comprises ethical issues in biomedicine, health care and biology, and the broader issues of biotechnology. The aims of BIG are to: (1) support scholarly research in bioethics at Ghent University (2) educate and inform students, professionals, the public and public policymakers about bioethical issues (3) serve as an observatory of developments in bioethics at the regional, national and international level (4) serve as an interface between researchers, medical practitioners and ethicists (5) facilitate interdisciplinary discussion about ethical and regulatory issues related to bioethics (6) contribute to debates on public policy in bioethics. These aims are pursued by conducting original interdisciplinary research resulting in leading edge publications, offering courses, organising seminars, public lectures and international conferences, and assisting in the formulation and development of public policy. The members of BIG write, research and teach on a variety of topics, including the ethics of new reproductive technologies, genetics, stem cell and cloning research, transplantation medicine, ageing in health care decision-making, neuro-enhancement, end-of-life decision making and patenting in biotechnology and health care. In order to facilitate research, BIG has developed collaborative relationships with other research centres. BIG has also secured major research grants in a number of areas including the ethics of stem cell research, end-of-life decision making, neuro-enhancement, and the ethical dimensions of patents in biotechnology.